CHINA MEDICAL UNIVERSITY HOSPITAL
🇹🇼Taiwan
The Variation of Movement Related Cortical Potential, Cortico-cortical Inhibition, and Motor Evoked Potential in Intracerebral Implantation of Antologous Peripheral Blood Stem Cells(CD34)in Old Ischemic Stroke
- Conditions
- Stroke
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2010-11-11
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT01239602
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
- Conditions
- Cardiovascular DiseaseChronic Kidney Disease PatientsHigh L5 LevelHemodialytic PatientsHigh LDL Level
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2010-11-09
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT01236820
- Locations
- 🇨🇳
China Medical University Hospital, Taichung City, Taiwan
Efficiency Study of Siwu Tang to Treat Brain Hypoperfusion Syndrome
Not Applicable
- Conditions
- Brain Hypoperfusion SyndromeIschemia Brain
- First Posted Date
- 2010-10-15
- Last Posted Date
- 2010-10-15
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01221662
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia
Phase 1
- Conditions
- Bronchopulmonary DysplasiaExtremely Premature InfantsSevere BPD That Conventional Therapies Has FailedNo Severe Congenital Anomaliesno Severe IVH Neither Cystic PVL
- Interventions
- Biological: ucMSCsOther: Normal saline
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2010-09-23
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01207869
- Locations
- 🇨🇳
China Medical University Hospital, Taichung,, Taiwan
The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2013-10-07
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 801
- Registration Number
- NCT01188824
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Phase 1
- Conditions
- Extremely Premature InfantsPDAOral IbuprofenIV Ibuprofen
- Interventions
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2010-06-23
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT01149564
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
The Effect of a Diet- and Exercise- Related Weight Control Intervention Program on Obesity in Adult Aged 40 and Over
Not Applicable
Completed
- Conditions
- Metabolic SyndromeObesity
- Interventions
- Behavioral: Individualized educationBehavioral: Grouped education
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT01040546
- Locations
- 🇨🇳
Department of Famility Medicine,China Medical University Hospital, Taichung, Taiwan
N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
Phase 2
Completed
- Conditions
- Obsessive Compulsive Disorder
- First Posted Date
- 2009-12-15
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01031927
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
N-methylglycine (Sarcosine) Treatment for Depression
Phase 2
Completed
- Conditions
- Major Depressive DisorderDepressionMajor Depression
- Interventions
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00977353
- Locations
- 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia
Phase 2
Completed
- Conditions
- SchizophreniasPsychosesPsychotic DisordersSchizophrenic Disorders
- Interventions
- Drug: D-amino acid oxidase inhibition (DAAOI-1)Drug: placebo
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2011-07-11
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT00960219
- Locations
- 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
© Copyright 2025. All Rights Reserved by MedPath